CS346691A3 - Complexes containing s-(+)-phenylalkanoic acids and alpha-hydroxyalkanoic acids - Google Patents

Complexes containing s-(+)-phenylalkanoic acids and alpha-hydroxyalkanoic acids

Info

Publication number
CS346691A3
CS346691A3 CS913466A CS346691A CS346691A3 CS 346691 A3 CS346691 A3 CS 346691A3 CS 913466 A CS913466 A CS 913466A CS 346691 A CS346691 A CS 346691A CS 346691 A3 CS346691 A3 CS 346691A3
Authority
CS
Czechoslovakia
Prior art keywords
acids
alpha
complexes containing
phenylalkanoic
hydroxyalkanoic
Prior art date
Application number
CS913466A
Other languages
Czech (cs)
English (en)
Inventor
Henrich Hasko Prof Dr Paradies
Original Assignee
Medice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medice filed Critical Medice
Publication of CS346691A3 publication Critical patent/CS346691A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
CS913466A 1990-11-15 1991-11-15 Complexes containing s-(+)-phenylalkanoic acids and alpha-hydroxyalkanoic acids CS346691A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036459 1990-11-15

Publications (1)

Publication Number Publication Date
CS346691A3 true CS346691A3 (en) 1992-06-17

Family

ID=6418340

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913466A CS346691A3 (en) 1990-11-15 1991-11-15 Complexes containing s-(+)-phenylalkanoic acids and alpha-hydroxyalkanoic acids

Country Status (17)

Country Link
US (1) US5254728A (pt)
EP (1) EP0486964B1 (pt)
JP (1) JPH0656738A (pt)
KR (1) KR920009767A (pt)
CN (1) CN1061405A (pt)
AT (1) ATE137487T1 (pt)
AU (1) AU643168B2 (pt)
BR (1) BR9104995A (pt)
CA (1) CA2055682A1 (pt)
CS (1) CS346691A3 (pt)
DE (2) DE59107762D1 (pt)
ES (1) ES2089091T3 (pt)
HU (1) HUT59653A (pt)
MX (1) MX9102087A (pt)
NZ (1) NZ240618A (pt)
PL (1) PL292414A1 (pt)
ZA (1) ZA919076B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
JP4707201B2 (ja) * 1997-02-04 2011-06-22 千寿製薬株式会社 ピリドンカルボン酸の可溶化方法、その可溶化剤および可溶化されたピリドンカルボン酸からなる水性液剤
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
US20100222311A1 (en) * 2007-10-19 2010-09-02 Purdue Research Foundation Solid formulations of crystalline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166447B (pt) * 1985-11-27 1990-05-12 Ethicon Inc
DE3836863A1 (de) * 1988-10-27 1990-05-03 Klosa Josef Fluessige, geloeste antirheumatische arzneizubereitungen
DK0424028T3 (da) * 1989-10-17 1996-01-29 Merck & Co Inc S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars

Also Published As

Publication number Publication date
HUT59653A (en) 1992-06-29
CA2055682A1 (en) 1992-05-16
BR9104995A (pt) 1992-06-23
KR920009767A (ko) 1992-06-25
EP0486964A3 (en) 1992-12-16
CN1061405A (zh) 1992-05-27
EP0486964B1 (de) 1996-05-01
PL292414A1 (en) 1992-10-19
ATE137487T1 (de) 1996-05-15
ES2089091T3 (es) 1996-10-01
AU8790991A (en) 1992-05-21
DE59107762D1 (de) 1996-06-05
NZ240618A (en) 1994-10-26
MX9102087A (es) 1992-10-30
DE4137699A1 (de) 1992-05-27
JPH0656738A (ja) 1994-03-01
HU913573D0 (en) 1992-01-28
ZA919076B (en) 1992-08-26
US5254728A (en) 1993-10-19
EP0486964A2 (de) 1992-05-27
AU643168B2 (en) 1993-11-04

Similar Documents

Publication Publication Date Title
PL297610A1 (pt)
IL67697A (en) 6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them
HU911815D0 (en) Process for the production of medical preparations containing pravastatine for the prevention of, relapse after vasodilator operation
HU913216D0 (en) Process for the production of saturated hydroxy-alkyl-kinoline acids, and of medical preparations containing them
HU913776D0 (en) Process for the production of heparosane-n,o-sulphates, and medical preparations containing them as active agents
AU6405790A (en) Preparations containing colestyramine for reducing lipid levels
HU910929D0 (en) Process for the production of 2,8-dioxa-bicyclo/3,2,1/octane derivatives and medical preparations containing them
HU892994D0 (en) Process for the production of stabil medical preparations
AR243180A1 (es) Procedimiento para la obtencion de 3,4-dihidro-2h-benzopiranos sustituidos.
ZA853351B (en) 2-amino-3-ethoxycarbonylamino-6-(p-fluoro-benzylamino)-pyridine gluconate,process for its production and pharmaceutical preparations containing it
HU9101576D0 (en) Process for the production of medical preparations for decreasing heart-fibrillation
HU911750D0 (en) Process for the production of medical preparations containing substituted betha-hydroxy-ethylamines
ZA821637B (en) Oxazaphosphorin-4-thio-alkanesulfonic acids, neutral salts thereof, processes for the production thereof and pharmaceutical preparations containing them
HU9102385D0 (en) Process for the production of medical preparations
CS346691A3 (en) Complexes containing s-(+)-phenylalkanoic acids and alpha-hydroxyalkanoic acids
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
DK494088D0 (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
HU912517D0 (en) New 1-diphenyl-methyl-piperazine derivatives, process for their production, and for the production of medical preparations containing thereof
DK493988D0 (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
HUT44753A (en) Process for producing gem-dihalogen-1,8-diamino-4-azaoctane derivatives and pharmaceutical preparations comprising such compounds
EP0315536A3 (fr) Esters polyaromatiques d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
GR3005231T3 (pt)
HU904211D0 (en) Process for the production of medical preparations containing 10-amino-5,6-dihydro-11h-dibenzo/b,e/azepin-6,11-dion and its derivatives
HU9201080D0 (en) New adenozyne derivatives, medical preparations containing them, and process for their production
EP0325691A3 (en) Process for the solubilization of insoluble protein